Sciclone Pharmaceuticals Fund Forecast

Buy candidate since Oct 10, 2017 Gain 0.90%

No changes to the price of SciClone Pharmaceuticals fund on the last trading day (Tuesday, 31st Oct 2017). During the last trading day the fund fluctuated 0.448% from a day low at $11.15 to a day high of $11.20. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund is at the lower part of a narrow and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $11.12 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect SciClone Pharmaceuticals fund with a 90% probability to be traded between $11.25 and $11.52 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and funds seldom manage to go directly from the bottom of a trend up to the top. Funds turning up in the middle of a horizontal trend are therefore considered to be potential runners.

SCLN Signals & Forecast

There are mixed signals in the fund today. A sell signal was issued from a pivot top point on Thursday, October 05, 2017, and so far it has fallen -0.446%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while price remained unchanged. This may be an early warning, but it may also not. We still recommend that you pay attention over the next couple of days. The SciClone Pharmaceuticals fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the fund. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $11.15 and $11.14. A breakdown below any of these levels will issue sell signals. The fund had a Golden Star Signal on Tuesday, September 12, 2017 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the fund in question.

Support, Risk & Stop-loss for SciClone Pharmaceuticals fund

SciClone Pharmaceuticals finds support from accumulated volume at $11.10 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the fund tends to have very controlled movements and with good liquidity the risk is considered very low in this fund. During the last day, the fund moved $0.0500 between high and low, or 0.448%. For the last week the fund has had daily average volatility of 0.448%.

Our recommended stop-loss: $10.70 (-4.05%) (This fund has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 18 days ago.)

Trading Expectations (SCLN) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect SciClone Pharmaceuticals to open at $11.17, and during the day (based on 14 day Average True Range), to move between $11.12 and $11.18, which gives a possible trading interval of +/-$0.0539 (+/-0.48%) up or down from last closing price. If SciClone Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 0.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $11.20 (0.45%) than the support at $11.10 (0.45%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is SciClone Pharmaceuticals fund A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for SciClone Pharmaceuticals fund to perform well in the short-term period.

Current score: 2.670 Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 1, 2017 - $11.17 ( 0.149%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk